- Home
- AIFF vs TURN Comparison
AIFF vs TURN Comparison
Compare AIFF & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIFF
- TURN
- Stock Information
- Founded
- AIFF 2006
- TURN 1981
- Country
- AIFF Canada
- TURN United States
- Employees
- AIFF N/A
- TURN N/A
- Industry
- AIFF
- TURN Finance/Investors Services
- Sector
- AIFF
- TURN Finance
- Exchange
- AIFF NYSE
- TURN Nasdaq
- Market Cap
- AIFF 33.8M
- TURN 33.4M
- IPO Year
- AIFF N/A
- TURN N/A
- Fundamental
- Price
- AIFF $4.55
- TURN $3.35
- Analyst Decision
- AIFF
- TURN
- Analyst Count
- AIFF 0
- TURN 0
- Target Price
- AIFF N/A
- TURN N/A
- AVG Volume (30 Days)
- AIFF 40.1K
- TURN 15.4K
- Earning Date
- AIFF 08-19-2024
- TURN 11-11-2024
- Dividend Yield
- AIFF N/A
- TURN N/A
- EPS Growth
- AIFF N/A
- TURN N/A
- EPS
- AIFF N/A
- TURN N/A
- Revenue
- AIFF $64,000.00
- TURN $129,297.00
- Revenue This Year
- AIFF N/A
- TURN N/A
- Revenue Next Year
- AIFF N/A
- TURN N/A
- P/E Ratio
- AIFF N/A
- TURN N/A
- Revenue Growth
- AIFF N/A
- TURN 6.32
- 52 Week Low
- AIFF $3.05
- TURN $3.31
- 52 Week High
- AIFF $15.90
- TURN $4.47
- Technical
- Relative Strength Index (RSI)
- AIFF N/A
- TURN 40.66
- Support Level
- AIFF N/A
- TURN $3.32
- Resistance Level
- AIFF N/A
- TURN $3.39
- Average True Range (ATR)
- AIFF 0.00
- TURN 0.05
- MACD
- AIFF 0.00
- TURN 0.01
- Stochastic Oscillator
- AIFF 0.00
- TURN 43.60
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform") and the discovery and clinical development of biomarkers in support of better outcomes for people suffering from mental illnesses and cognitive disorders.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.